Legal Opinion
Aventis Pharma S.A. v. Amphastar Pharmaceuticals, Inc.
Court of Appeals for the Federal Circuit
Decided May 14, 2008No. 2007-1280PublishedCited by 25 opinions
1Opinion of the Court
PROST, Circuit Judge.
This infringement case returns to us for the second time after remand to the district court on the issue of whether Aventis committed inequitable conduct before the United States Patent and Trademark Office (“PTO”). In our earlier opinion, we held that the dosage of the prior art composition used in half-life comparisons with the patented composition was information material to patentability, but we remanded to the district court to determine whether ' there was an intent to deceive by Aventis in failing to disclose the dosage. After a trial on the matter, the district…
2Cases cited17 opinions
- Kingsdown Medical Consultants, Ltd. And E.R. Squibb & Sons, Inc. v. Hollister IncorporatedCourt of Appeals for the Federal Circuit · 1988
- Molins Plc, and John Coventry Smith, Jr. v. Textron, Inc., Kearney & Trecker Corporation, and Avco CorporationCourt of Appeals for the Federal Circuit · 1995
- Dsu Medical Corporation v. Jms Co., LtdCourt of Appeals for the Federal Circuit · 2006
- Paragon Podiatry Laboratory, Inc. v. Klm Laboratories, Inc.Court of Appeals for the Federal Circuit · 1993
- Kimberly-Clark Corporation v. Johnson & Johnson and Personal Products CompanyCourt of Appeals for the Federal Circuit · 1984
12 more not listed; retrieve them via the Exa API.
3Cited by25 opinions
- Therasense, Inc. v. Becton, Dickinson and Co.Court of Appeals for the Federal Circuit · 2011
- Cooper Technologies Co. v. DudasCourt of Appeals for the Federal Circuit · 2008
- Eisai Co., Ltd. v. Teva Pharmaceuticals USA, Inc.District Court, D. New Jersey · 2009
- Amphastar Pharmaceuticals Inc. v. Aventis Pharma SACourt of Appeals for the Ninth Circuit · 2017
- Medisim Ltd. v. Bestmed LLCDistrict Court, S.D. New York · 2012
20 more not listed; retrieve them via the Exa API.